KMTS - CIK 0001877184
KESTRA MEDICAL TECHNOLOGIES, LTD. trades as KMTS and has a market capitalization of $1.12 B, making it the #2558 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $59.81M, up 115.1% from the prior year and net income of -$113.81M. This page tracks KESTRA MEDICAL TECHNOLOGIES, LTD. through 105 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-18 |
| Insider sale notice | 144 | 2026-05-15 |
| Insider trade | 4 | 2026-04-16 |
| Insider sale notice | 144 | 2026-04-15 |
| SCHEDULE 13G/A | - | 2026-04-08 |
| S-3ASR | - | 2026-04-01 |
| Insider trade | 4 | 2026-03-30 |
| Insider trade | 4 | 2026-03-19 |
The largest companies sharing KESTRA MEDICAL TECHNOLOGIES, LTD.'s SEC industry classification (surgical & medical instruments & apparatus).
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) has a market capitalization of $1.12 B as of 2026-06-10, ranking #2558 among US-listed companies.
KESTRA MEDICAL TECHNOLOGIES, LTD. reported revenue of $59.81M for fiscal year 2025, an increase of 115.1% year over year.
In its latest fiscal year KESTRA MEDICAL TECHNOLOGIES, LTD. reported a net loss of $113.81M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.